GLP1R and type 2 diabetes mellitus: GLP1-RAs mitigate the impact of T2DM on the progression of DKD by suppressing many of the inflammatory signaling pathways like the renal nicotinamide adenine dinucleotide phosphate (NADPH) oxidase [15,68].